|
Marc R. Wilkins is an Australian scientist who is credited with the concept of the proteome, and is a Professor in the School of Biotechnology and Biomolecular Sciences at the University of New South Wales, Sydney. Wilkins coined the term proteome in 1994,〔(UNSW Staff Bio: Professor Marc Wilkins )〕 whilst developing the concept as a PhD student at Macquarie University, Sydney, Australia;〔"(New lab to help Australia’s next crop of eminent scientists )", ''Postgrad and Beyond: Science'', Macquarie University. Published 2005. Accessed 18 January 2009.〕 this being a generalisation of the concept of the genome to encompass the set of all proteins that can be produced through the genome, through alternative splicing and post-transcriptional modification of messenger RNA. ==Career== Dr Wilkins held a post-doctoral fellowship from 1995–1997 at the University of Geneva, Switzerland, working with Prof Denis Hochstrasser and Dr Amos Bairoch. He co-developed many of the protein analysis tools available on the ExPASy web server. He subsequently served as a senior post-doctoral fellow in the Australian Proteome Analysis Facility,〔(Macquarie University/CSIRO Internet Innovation Centre Technology Trends Seminar, 2003: Speaker Bio – Marc Wilkins ), Published 2003. Accessed 18 January 2009.〕 which was established by the Australian Government in 1995 as the world's first dedicated proteome research centre.〔 In 1997 he co-edited the first book on proteomics, ''Proteome Research: New Frontiers in Functional Genomics'' (Wilkins et al. (eds), Springer Verlag), which has sold more than 4,000 copies.〔〔 He was a co-founder of the proteomics company Proteome Systems Ltd. It was established in January 1999, and listed on the Australian Securities Exchange in 2004. Dr Wilkins worked in Proteome Systems full-time for 6 years as leader of its bioinformatics Research and Development team.〔 It was awarded IBM's "Rookie of the Year Award" for companies in the Asia-Pacific region, in 2003.〔 Proteome Systems Inc has since been renamed Tyrian Diagnostics,.〔"(New Name for Proteome Systems )"]〕 In 2008, Dr Wilkins co-founded the regnerative medicine company, Regeneus.〔(Regeneus Pty. Ltd )〕 This company has established treatments for osteoarthritis using autologous adult stem cells. Dr Wilkins is currently a Professor of Systems Biology at the University of New South Wales,〔 and is the director of the Systems Biology Initiative〔(Systems Biology Initiative Staff Bio: Professor Marc Wilkins )〕 and the Ramaciotti Centre for Gene Function Analysis.〔(Ramaciotti Centre for Gene Function Analysis )〕 His latest research focus is protein interaction networks (the interactome)〔"(Another dimension in protein interaction )", ''Australian Life Scientist'', Published September/October 2009. Accessed 1 July 2010.〕 and Systems Biology,.〔 In 2012, Marc Wilkins is awarded the ASBMB Beckman Coulter Discovery Science Award for 2012.〔(ASBMB Awards descriptions )〕 This prize is awarded to an ASBMB member for distinguished contributions to the field of biochemistry and molecular biology. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Marc Wilkins (geneticist)」の詳細全文を読む スポンサード リンク
|